Vima Therapeutics is a startup based in the United States, 1 tracked investor.
Based in the United States, Vima Therapeutics is a startup. Brouky records 1 investor associated with the company.
Vima Therapeutics develops novel oral therapies targeting muscarinic cholinergic receptors to treat movement disorders such as dystonia and Parkinson's disease, aiming to improve patients' control over their movement.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.